Article · Wikipedia archive · Last revised Jun 17, 2026

DODB

DODB, also known as 2,5-dimethoxy-4,6-dibromoamphetamine or as 6-bromo-DOB, is a psychedelic drug of the phenethylamine, amphetamine, and DOx families related to DOB. It is the 6-bromo derivative of DOB and the 4,6-dibromo derivative of 2,5-dimethoxyamphetamine. The drug has a dose range of 5 to 8 mg orally and a duration of 12 to 20 hours. For comparison, DOB has a dose of 1 to 3 mg and a duration of 18 to 30 hours. DODB is described as having largely the same effects as DOB. However, it is said that the drug may have somewhat greater visual effects than DOB and that its physical side effects appear to be less pronounced than those of DOB. DODB was synthesized and tested by P. Rausch in the 1990s or 2000s. It was described in the scientific literature by Daniel Trachsel in 2013, who cited personal communication with Rausch as the source for the information. The drug is a controlled substance in Canada under phenethylamine blanket-ban language.

Last revised
Jun 17, 2026
Read time
≈ 1 min
Length
307 w
Citations
12
Source
Wikipedia ↗
DODB
Clinical data
Other names6-Bromo-DOB; 2,5-Dimethoxy-4,6-dibromoamphetamine; 2,4-Dibromo-3,6-dimethoxyamphetamine
Routes of
administration		Oral1
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of action12–20 hours1
Identifiers
  • 1-(2,4-dibromo-3,6-dimethoxyphenyl)propan-2-amine
Chemical and physical data
FormulaC11H15Br2NO2
Molar mass353.054 g·mol−1
3D model (JSmol)
  • COc1c(Br)cc(c(c1Br)CC(N)C)OC
  • InChI=1S/C11H15Br2NO2/c1-6(14)4-7-9(15-2)5-8(12)11(16-3)10(7)13/h5-6H,4,14H2,1-3H3
  • Key:MFEJTCMFVXAELO-UHFFFAOYSA-N

DODB, also known as 2,5-dimethoxy-4,6-dibromoamphetamine or as 6-bromo-DOB, is a psychedelic drug of the phenethylamine, amphetamine, and DOx families related to DOB.1 It is the 6-bromo derivative of DOB and the 4,6-dibromo derivative of 2,5-dimethoxyamphetamine (2,5-DMA; DOH).1 The drug has a dose range of 5 to 8 mg orally and a duration of 12 to 20 hours.1 For comparison, DOB has a dose of 1 to 3 mg and a duration of 18 to 30 hours.1 DODB is described as having largely the same effects as DOB.1 However, it is said that the drug may have somewhat greater visual effects than DOB and that its physical side effects appear to be less pronounced than those of DOB.1 DODB was synthesized and tested by P. Rausch in the 1990s or 2000s.12 It was described in the scientific literature by Daniel Trachsel in 2013, who cited personal communication with Rausch as the source for the information.1 The drug is a controlled substance in Canada under phenethylamine blanket-ban language.3

See also

See also

References

References

  1. Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. p. 921. ISBN 978-3-03788-700-4. OCLC 858805226. Archived from the original on 21 August 2025.
  2. Rausch P (January 1995). Leuner H, Schlichting M (eds.). Jahrbuch des Europäischen Collegiums für Bewußtseinsstudien: 1995 [Yearbook of the European College for the Study of Consciousness: 1995] (in German and English). Vol. 4. Berlin: VWB. ISBN 3861354071. ISSN 0942-7600. OCLC 28636362.
  3. "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
External links